Guggenheim Capital LLC Pfizer Inc Transaction History

Guggenheim Capital LLC

$14 Billion
Q1 2024

A detailed history of Guggenheim Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 1,472,226 shares of PFE stock, worth $41.2 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

1,472,226

Previous 1,419,317 3.73%

Holding current value

$41.2 Million

Previous $40.9 Million 0.02%

% of portfolio

0.29%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $1.37 Million - $1.57 Million	52,909 Added 3.73%	1,472,226 $40.9 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.42 Million - $1.84 Million	54,297 Added 3.98%	1,419,317 $40.9 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $5.08 Million - $5.94 Million	158,352 Added 13.12%	1,365,020 $45.3 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $2.54 Million - $2.94 Million	70,367 Added 6.19%	1,206,668 $44.3 Million
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $3,348 - $4,358	-85 Reduced 0.01%	1,136,301 $46.4 Million

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $1.94 Million - $2.54 Million	-46,526 Reduced 3.93%	1,136,386 $58.3 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $2 Million - $2.44 Million	-45,763 Reduced 3.72%	1,182,912 $51.8 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $7.32 Million - $8.68 Million	-157,294 Reduced 11.35%	1,228,675 $64.4 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $7.31 Million - $9.06 Million	-159,853 Reduced 10.34%	1,385,969 $71.8 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.21 Million - $1.79 Million	29,250 Added 1.93%	1,545,822 $91.3 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $2.85 Million - $3.66 Million	72,600 Added 5.03%	1,516,572 $65.2 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $629,717 - $713,364	-17,536 Reduced 1.2%	1,443,972 $56.5 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $1.36 Million - $1.53 Million	40,497 Added 2.85%	1,461,508 $53 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $2.5 Million - $3.18 Million	74,633 Added 5.54%	1,421,011 $52.3 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $1.56 Million - $1.83 Million	-49,081 Reduced 3.52%	1,346,378 $49.4 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $2.36 Million - $2.87 Million	78,465 Added 5.96%	1,395,459 $45.6 Million
Q1 2020 Jun 02, 2020	SELL	$27.03 - $38.62 $2.22 Million - $3.18 Million	-82,260 Reduced 5.88%	1,316,994 $43 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $2.5 Million - $2.84 Million	-76,061 Reduced 5.16%	1,399,254 $54.8 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $357,390 - $463,430	11,000 Added 0.75%	1,475,315 $53 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $269,325 - $302,390	-7,283 Reduced 0.49%	1,464,315 $63.4 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $2.56 Million - $2.81 Million	68,261 Added 4.86%	1,471,598 $62.5 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $9.67 Million - $11 Million	-251,486 Reduced 15.2%	1,403,337 $61.3 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $3.06 Million - $3.71 Million	88,744 Added 5.67%	1,654,823 $72.9 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $53.5 Million - $57.1 Million	-1,623,338 Reduced 50.9%	1,566,079 $56.8 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $2.39 Million - $2.77 Million	-74,915 Reduced 2.29%	3,189,417 $113 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $5.05 Million - $5.35 Million	151,711 Added 4.87%	3,264,332 $118 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $96.5 Million - $106 Million	3,112,621	3,112,621 $111 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Pfizer Inc Transaction History